Cargando…

The Association Between Cervical Human Papillomavirus Infection and Subsequent HIV Acquisition in Tanzanian and Ugandan Women: A Nested Case-Control Study

Objective This study was performed to analyze the associations between cervical human papillomavirus (HPV) infection and human immunodeficiency virus (HIV) acquisition, using cervical samples from previous studies in Tanzania and Uganda. Methods. A total of 161 adult women who acquired HIV infection...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallagher, Katherine E., Baisley, Kathy, Grosskurth, Heiner, Vallely, Andrew, Kapiga, Saidi, Vandepitte, Judith, Kamali, Anatoli, De Sanjosé, Silvia, Changalucha, John, Hayes, Richard, Watson-Jones, Deborah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907415/
https://www.ncbi.nlm.nih.gov/pubmed/26951818
http://dx.doi.org/10.1093/infdis/jiw094
Descripción
Sumario:Objective This study was performed to analyze the associations between cervical human papillomavirus (HPV) infection and human immunodeficiency virus (HIV) acquisition, using cervical samples from previous studies in Tanzania and Uganda. Methods. A total of 161 adult women who acquired HIV infection during follow-up and 464 individually matched HIV-seronegative controls were selected from 5 cohorts of women working in bars and recreational facilities. Stored cervical samples were tested for 37 HPV genotypes, using a polymerase chain reaction assay (Roche Linear Array genotyping assay). Multivariate matched analysis using conditional logistic regression was performed to evaluate HPV infection, persistence, and clearance as predictors of HIV acquisition. Results. HIV seroconverters were significantly more likely than controls to frequently drink alcohol and to be infected with Chlamydia trachomatis, Neisseria gonorrhoeae, or herpes simplex virus type 2. There was no evidence of an association between HIV acquisition and any detectable HPV at the visit prior to HIV seroconversion (adjusted odds ratio, 1.02; 95% confidence interval, .66–1.57) or between HIV acquisition and persistent HPV infection (defined as 2 positive HPV genotype–specific test results at least 6 months apart), cleared HPV infection (defined as a positive HPV test result followed by negative HPV genotype–specific test result), or newly acquired HPV infection, compared with HPV-negative women. Conclusions. There was no evidence of association between HPV infection status and subsequent HIV acquisition. These results stand in contrast to other observational studies.